Related Experiment Videos
Helicobacter pylori and gastric malignancies
Antonia R Sepulveda1, Luiz Gonzaga V Coelho
1University of Pittsburgh Medical Center, Department of Pathology, University of Pittsburgh, Pittsburgh, PA 15213, USA. sepulvedaar@msx.upmc.edu
Helicobacter
|August 29, 2002
Summary
Helicobacter pylori infection is linked to gastric cancer, with a 2.9% development rate in Japanese patients. Eradicating H. pylori may help regress precancerous lesions, but more research is needed to confirm reduced malignancy risk.
Area of Science:
- Gastroenterology
- Oncology
- Infectious Diseases
Background:
- The epidemiological link between Helicobacter pylori (H. pylori) and gastric carcinoma is established.
- Gastric carcinoma development occurs at a reported rate of 2.9% in the Japanese population with H. pylori gastritis over 7.8 years.
Purpose of the Study:
- To review the current understanding of H. pylori's role in gastric carcinogenesis.
- To explore the potential benefits of H. pylori eradication on precancerous lesions and malignancy development.
- To identify criteria for H. pylori screening and surveillance for gastric malignancy.
- To evaluate H. pylori eradication therapy for MALT lymphoma.
Main Methods:
- Review of epidemiological studies linking H. pylori to gastric carcinoma.
- Analysis of studies on H. pylori eradication and regression of gastric atrophy and intestinal metaplasia.
- Examination of research on low-grade MALT lymphoma, including EUS staging and t(11;18) translocation.
- Exploration of microarray studies on gene expression pathways activated by H. pylori in gastric epithelial cells.
Main Results:
- H. pylori gastritis is associated with a significant risk of gastric carcinoma.
- Gastric atrophy and intestinal metaplasia may partially regress post-eradication, but long-term impact on malignancy requires confirmation.
- Limited progress in identifying criteria for individualized H. pylori screening.
- Clinical and molecular features, such as lymphoma stage and t(11;18), may predict response to H. pylori eradication in low-grade MALT lymphoma.
- New molecular pathways involved in H. pylori-induced gastric carcinogenesis have been identified.
Conclusions:
- H. pylori eradication shows promise for managing precancerous gastric lesions and MALT lymphoma.
- Further large-scale prospective studies are necessary to confirm the impact of H. pylori eradication on gastric malignancy development and high-grade MALT lymphoma.
- Continued research into molecular pathways is crucial for understanding H. pylori carcinogenesis.